Premarket Decliner
MCRB Seres Therapeutics14.09-0.22-1.5%
Premarket:11.45-2.64 (-18.7%)
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
Globe NewswireThu, 12-Feb 7:00 AM
MCRB Seres Therapeutics18.22-10.41 (-36.4%)
MCRB Seres Therapeutics21.63+4.97 (+29.8%)
MCRB Seres Therapeutics19.73+0.50 (+2.6%)
MCRB Seres Therapeutics16.48+0.51 (+3.2%)